BioSpace News Archive

Job Trends

International Isotopes Inc. Announces Financial Results for The Third Quarter 2019

The Company Reports Net Income of $236,462 For The Three-Month Period Ended September 30, 2019

November 19, 2019
·
10 min read
Job Trends

Swisslog Healthcare Embraces the Evolving Healthcare Landscape by Focusing on the Medication Supply Chain

The company announces a new brand position and corporate identity consistent with providing hospitals with connectivity between transport and pharmacy automation solutions leading to better patient outcomes

November 19, 2019
·
3 min read
Business

Centric Health Corporation Opens the Market

Centric Health Corporation commenced trading on Toronto Stock Exchange on September 1, 2009.

November 19, 2019
·
1 min read
BioMidwest

Life Spine Announces First Cases With the CENTERLINE® Modular Thoracolumbar Spinal System

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced the initial surgeries of the CENTERLINE Modular Thoracolumbar Spinal System.

November 19, 2019
·
2 min read
Pharm Country

CURE® to Host Patient-Focused Sessions on Multiple Myeloma in Charlotte

The full-day event seeks to educate and inform patients with multiple myeloma while challenging their thinking about the disease

November 19, 2019
·
2 min read
Business

EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility

There were no other changes made to the term loan agreement.

November 19, 2019
·
7 min read
Business

Humana Pharmacy Wins Specialty Pharmacy Patient Choice Award, Two Years in a Row

Award honors specialty pharmacies for their commitment to patients

November 19, 2019
·
4 min read
Deals

Traditions Health Expands Presence in Arizona; Acquires Pathways Hospice

Traditions Health, LLC, a hospice and home health provider in Texas, California and Arizona, announced that it has acquired Pathways Hospice Pathways is a provider of hospice services based in Tucson.

November 19, 2019
·
1 min read
Drug Development

Allergan Announces Positive Phase 3 ACHIEVE II Trial Results for Ubrogepant Published in The Journal of the American Medical Association

Pivotal Phase 3 clinical trial reinforced efficacy, safety and tolerability of ubrogepant, an orally-administered CGRP receptor antagonist

November 19, 2019
·
9 min read
Business

BioMatrix Announces 2019 Academic Scholarship Recipients

Program Honors Memory of Bleeding Disorder Community Members

November 19, 2019
·
4 min read